ArticleJournal of asthma and allergy2025

Efficacy and Safety of Omalizumab Combined with Allergen-Specific Immunotherapy in the Treatment of Moderate-to-Severe Allergic Asthma: A Prospective Cohort Study in a Chinese Population.

Na Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.